Stanford-India Biodesign is a collaboration between Stanford University and institutions in India to [1] develop leaders in medical technology innovation, [2] create technologies for India, and [3] grow the Indian medical technology industry. The program offers fellowships for Indian citizens to develop technologies, trains engineers and doctors, and works to bridge academia and industry through various courses, internships, and a new innovation center. The goal is to increase India's capacity for medical technology innovation to address the country's healthcare needs.

1. Stanford-India Biodesign
Rajiv Doshi, MD
Executive Director (US), Stanford-India Biodesign
Consulting Assistant Professor of Medicine
Lecturer in Mechanical Engineering
Stanford University
rdoshi@stanford.edu
1

2. Stanford-India Biodesign: Mission
 To develop leaders in medical technology innovation in India
 To create medical technologies for India
 To fuel growth of the Indian medical technology industry
Educate. Collaborate. Innovate.
2

3. Stanford-India Biodesign Institutions
 All India Institute of Medical Sciences (AIIMS)
 Indian Institute of Technology (IIT) Delhi
 Stanford University
3

4. Stanford-India Biodesign Sponsors
 Department of Biotechnology, Government of India
 Indo-US Science & Technology Forum
 Lemelson Foundation
 Stryker Corporation
 Orbees Medical
 Artiman Ventures
4

5. Key Objectives
 Ecosystem development
 Human resources development
 “Training the trainers”
 Training large numbers of engineers and physicians at India’s top
institutions
 Building sites of medical technology excellence
 Bridging academia and industry
5

6. Team (Stanford)
 Rajiv Doshi, MD
– Executive Director, Stanford-India Biodesign (US)
– Consulting Assistant Professor of Medicine, Stanford University
 Anurag Mairal, PhD
– Associate Director, Program Development, Stanford-India
Biodesign
 Uday Kumar, MD
– Associate Director, Curriculum, Stanford-India Biodesign
 Christine Kurihara
– Associate Director, Operations, Stanford-India Biodesign
 Saloni Doshi
– Strategic Advisor, Stanford-India Biodesign
 Paul Yock, MD
– Director of Stanford Biodesign
– Professor of Cardiology, Stanford University
6

7. Team (India)
 Balram Bhargava, MD
– Executive Director, Stanford-India Biodesign (India)
– Professor of Cardiology, AIIMS
 Alok Ray, PhD
– Director, Stanford-India Biodesign (India)
– Professor of Biomedical Engineering, IIT Delhi
 Sakti Srivastava, MD
– Associate Director, Academic Outreach (US), Stanford-India
Biodesign
– Consulting Associate Professor of Surgery, Stanford University
 Sandeep Singh, MD
– Associate Professor of Cardiology, AIIMS
7

8. About Stanford Biodesign
 Created in 2000 by cardiologist Paul Yock, MD to train leaders in
medical technology innovation
 Series of initiatives to promote medical technology innovation and
entrepreneurship
– A fellowship program leading to VC backed companies
– Direct and indirect affiliation with numerous courses
• Engineering (Mechanical, chemical, electrical, industrial)
• Business
• Medicine
• Law
– National conferences to promote best practices in medical technology
innovation
 Strong ties to industry, venture capital
8

9. Stanford Biodesign:
One Course Leads to Many Others
 ME 394 Medical Device Design
 BIOE 70Q Medical-Device Innovation
 BIOE 374 Biodesign Innovation
 EE 202 Medical Electronics
 IMMUNOL 230 Introduction to Medicine
 ME 208 Patent Law and Strategy for Innovators and Entrepreneurs
 ME 382 Biomedical Device Design & Evaluation
 MED 217 Medico-Technological Frontiers of Digestive Diseases
 MED 276 Introduction to the Medical Technology Industry and Its Career
 MS&E 256 Technology Assessment and Regulation of Medical Devices
 NSUR 278 From Science to Business: Innovation in Neurological Disease
 NSUR 279 Concepts in Drug Device Combination Products
9

10. Biodesign Companies to Date
10

11. Initial Planning Meetings in Delhi:
January 2007
11

12. Stanford-India Biodesign Offerings
 Stanford-India Biodesign Fellowships (Begun)
 India Biodesign Internships at AIIMS/IIT Delhi (Begun)
 Medical Device Innovation courses to be offered across India (2010)
 Core Stanford Biodesign innovation lectures to be offered online (Begun)
 Global student/faculty exchanges (Begun)
 National Indian Med Tech summit (Begun)
 Support of nationwide innovation contests (Begun)
 Creation of SIB Centers
– 2008: First SIB Center in New Delhi (Begun)
 www.indiabiodesign.org networking community (Begun)
12

13. Stanford-India Biodesign Fellowships
 1-2 year fellowships housed at Stanford and New Delhi
 Interdisciplinary, team-based learning combining engineering, clinical and
business trainees
 Intensive exposure to medical needs-finding within the Indian setting
 Teams invent, develop, patent and commercialize technologies
 Mentoring by world class faculty at Stanford, IIT Delhi and AIIMS
 Mentoring by “real world” industry experts and advisors in the US and
India
– Technology innovators, legal, venture capital
13

14. Fellowship Selection Process
 300 worldwide applicants (Indian citizens)
 17 Semi-finalists interviewed in New Delhi
 8 Finalists interviewed at Stanford
 5 Fellows selected
14

15. 2008 Fellows
 Nishith Chasmawala
– Johnson & Johnson, Medtronic
 Srinivas Jaggu
– Kirloskar, General Electric
 Jayant Karve
– General Electric
 Amit Sharma
– IIT Delhi
 Sandeep Singh, MD
– Associate Professor of Cardiology, AIIMS
 New Fellows arrived January 2009
– Includes 2 Professors from IIT Madras, IIT Delhi
15

16. Fellowship Timeline
16

17. Post-Fellowship Activities
 Track 1
– Start med tech company in India
 Track 2
– Join multinational or other established med tech company
– Pursue “intrapreneurial” activities
 Track 3
– Return to academia
– Teach Biodesign fundamentals in India
All fellows are expected to remain in India and maintain a mentoring relationship with SIB
17

18. Indian Biodesign Internships at AIIMS/IIT Delhi
 3-6 month concentrated exposure at AIIMS/IIT Delhi
 Goal is to get (less complicated) products to market quickly
 Teaching staff to include Fellows, Professors at AIIMS, IIT
 Interns to include engineering students and engineers/business people
from industry
 Began October 2008
18

19. Medical Device Innovation Course at Multiple
Indian Universities
 To be broadly deployed at top engineering institutions in India
 Based on similar Medical Device Design course at Stanford
 Customized for India
 Can accommodate ~30 undergraduate and graduate students
 Part didactic, part project (prototyping)
 Core lectures designed by Stanford-India Biodesign
 Projects led by practicing physicians
– 3-4 students per team
19

20. First Annual Indian Med Tech Summit
20

21. First Stanford-India Biodesign Centre
(AIIMS—New Delhi)
21

22. Support of National Med Tech Innovation Contest
Through IIT Bombay
22

23. www.indiabiodesign.org
23

24. Potential Benefit for India
 Greatly increased exposure to medical technology innovation at
university level to significantly increase graduates with interests
in medical technology careers
 Development of academic faculty capable of training dozens of
future med tech leaders per year
 Development of industry leaders capable of leading
entrepreneurial or “intrapreneurial” initiatives
 Development of New Delhi (and second location TBD) to serve
as hubs of medical technology innovation
 Development of an ecosystem that is sorely lacking
 Matching of job applicants with employers
 Devices made expressly for the needs of Indians and others in
developing countries
24

25. Getting Involved
 Advisors and mentors still needed
 Funding needed to scale program
– Corporates
– VCs
– Foundations
– Individuals
 If interested, please email me at rdoshi@stanford.edu
We need the community’s help to achieve the greatest impact
25